The Role of Metabolic Parameters in FDG PET-CT Imaging for Predicting Progression-Free Survival in Radioiodine Refractory Thyroid Cancer: A Single-Center Study

被引：0
|
作者：
Khatami, Alireza [1 ]
Sutherland, Duncan [2 ]
机构：
[1] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada
[2] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242421
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei
    Masatoshi Hotta
    Ryogo Minamimoto
    Yoshimasa Gohda
    Toru Igari
    Hideaki Yano
    European Radiology, 2019, 29 : 5709 - 5716
  • [22] Application of preoperative FDG-PET/CT parameters for predicting prognosis of high-grade neuroendocrine cervical cancer: A single-center, retrospective
    Kim, Dae-Yeon
    Kim, Yong Man
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S191 - S192
  • [23] Evaluating the Role of Mid-Treatment and Post-Treatment FDG-PET/CT in Predicting Progression-Free Survival and Distant Metastasis of Anal Cancer Patients Treated with Chemoradiotherapy
    Zhang, H.
    Wang, J.
    Chuong, M.
    D'Souza, W.
    Latifi, K.
    Saeed, Nadia
    Tan, S.
    Choi, W.
    Hoffe, S.
    Shridhar, R.
    Moros, E.
    Lu, W.
    MEDICAL PHYSICS, 2015, 42 (06) : 3325 - 3325
  • [24] Tumor and metastatic lymph nodes metabolic activity on 18F-FDG PET/CT to predict progression-free survival in locally advanced cervical cancer
    Song, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S263 - S264
  • [25] Tumor and metastatic lymph nodes metabolic activity on 18F-FDG-PET/CT to predict progression-free survival in locally advanced cervical cancer
    Song, Jinling
    Pang, Weiqiang
    Yi, Heqing
    Ji, Jianfeng
    Ye, Xuemei
    Li, Linfa
    ABDOMINAL RADIOLOGY, 2024, 49 (03) : 975 - 984
  • [26] Tumor and metastatic lymph nodes metabolic activity on 18F-FDG-PET/CT to predict progression-free survival in locally advanced cervical cancer
    Jinling Song
    Weiqiang Pang
    Heqing Yi
    Jianfeng Ji
    Xuemei Ye
    Linfa Li
    Abdominal Radiology, 2024, 49 : 975 - 984
  • [27] Early 18F-FDG PET/CT imaging well correlates with Progression-Free Survival in Hodgkin's lymphoma patients
    Paolini, R.
    Rampin, L.
    Rodella, E.
    Banti, E.
    Rubello, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S385 - S386
  • [28] Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
    Weber, Manuel
    Kersting, David
    Riemann, Burkhard
    Brandenburg, Tim
    Fuhrer-Sakel, Dagmar
    Grunwald, Frank
    Kreissl, Michael C.
    Dralle, Henning
    Weber, Frank
    Schmid, Kurt Werner
    Herrmann, Ken
    Jentzen, Walter
    Grafe, Hong
    Rischpler, Christoph
    Theurer, Sarah
    Bockisch, Andreas
    Nagarajah, James
    Fendler, Wolfgang P.
    CLINICAL CANCER RESEARCH, 2022, 28 (19) : 4194 - 4202
  • [29] [18F] NaF PET/CT imaging biomarkers of progression-free survival in metastatic prostate cancer.
    Harmon, Stephanie
    Perk, Tim
    Eickhoff, Jens C.
    Staab, Mary Jane
    Choyke, Peter L.
    Dahut, William L.
    Apolo, Andrea B.
    Humm, John
    Larson, Steven M.
    Morris, Michael J.
    Perlman, Scott
    Liu, Glenn
    Jeraj, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [30] Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free Survival
    Schank, Timo E.
    Forschner, Andrea
    Sachse, Michael Max
    Dimitrakopoulou-Strauss, Antonia
    Sachpekidis, Christos
    Stenzinger, Albrecht
    Volckmar, Anna-Lena
    Enk, Alexander
    Hassel, Jessica C.
    CANCERS, 2021, 13 (11)
12345